Literature DB >> 22515094

Carbosilane dendrimers are a non-viral delivery system for antisense oligonucleotides: characterization of dendriplexes.

Elzbieta Pedziwiatr-Werbicka1, Dzmitry Shcharbin, Jan Maly, Marek Maly, Marian Zaborski, Barbara Gabara, Paula Ortega, F Javier de la Mata, Rafael Gómez, M Angeles Muñoz-Fernandez, Barbara Klajnert, Maria Bryszewska.   

Abstract

The success of gene therapy depends on the development of suitable carriers, and because of their architecture dendrimers are promising tools for gene delivery. This research concerns the use of second generation carbosilane dendrimers as carriers for anti-HIV oligodeoxynucleotides (ODNs). The aim was to characterize complexes formed by positively charged dendrimers and negatively charged oligonucleotides using a fluorescence method, laser Doppler electrophoresis, dynamic light scattering (DLS), atomic force microscopy (AFM), transmission electron microscopy (TEM) and molecular modeling. The zeta-potential of ODNs increased from -25 mV to positive values after the addition of dendrimers. DLS and TEM revealed that the diameters of dendriplexes ranged from 75 to 240 nm and from 50 to 260 nm, respectively, and this was dependent on the type of dendrimer and the molar ratios of the complexes formed; complexes were stable for between 100 and 300 minutes. AFM measurements and molecular modeling studies were carried out to determine the structure and size of dendriplexes. The physicochemical properties of the dendriplexes studied and data from previous research suggest that carbosilane dendrimers are good candidates for nucleic acid delivery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22515094     DOI: 10.1166/jbn.2012.1369

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  6 in total

1.  Novel gene delivery systems.

Authors:  Steffy B Manjila; Jomon N Baby; Elambilan N Bijin; Icey Constantine; Kannissery Pramod; Janardhanan Valsalakumari
Journal:  Int J Pharm Investig       Date:  2013-01

2.  Silver Nanoparticles Surface-Modified with Carbosilane Dendrons as Carriers of Anticancer siRNA.

Authors:  Elżbieta Pędziwiatr-Werbicka; Michał Gorzkiewicz; Katarzyna Horodecka; Viktar Abashkin; Barbara Klajnert-Maculewicz; Cornelia E Peña-González; Javier Sánchez-Nieves; Rafael Gómez; F Javier de la Mata; Maria Bryszewska
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 3.  Function Oriented Molecular Design: Dendrimers as Novel Antimicrobials.

Authors:  Sandra García-Gallego; Gianluigi Franci; Annarita Falanga; Rafael Gómez; Veronica Folliero; Stefania Galdiero; Francisco Javier de la Mata; Massimiliano Galdiero
Journal:  Molecules       Date:  2017-09-21       Impact factor: 4.411

Review 4.  Dendrimers Show Promise for siRNA and microRNA Therapeutics.

Authors:  Volha Dzmitruk; Evgeny Apartsin; Aliaksei Ihnatsyeu-Kachan; Viktar Abashkin; Dzmitry Shcharbin; Maria Bryszewska
Journal:  Pharmaceutics       Date:  2018-08-08       Impact factor: 6.321

5.  Poly(lysine) Dendrimers Form Complexes with siRNA and Provide Its Efficient Uptake by Myeloid Cells: Model Studies for Therapeutic Nucleic Acid Delivery.

Authors:  Michał Gorzkiewicz; Olga Kopeć; Anna Janaszewska; Małgorzata Konopka; Elżbieta Pędziwiatr-Werbicka; Irina I Tarasenko; Valeriy V Bezrodnyi; Igor M Neelov; Barbara Klajnert-Maculewicz
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

6.  Effect of Terminal Groups of Dendrimers in the Complexation with Antisense Oligonucleotides and Cell Uptake.

Authors:  Valeria Márquez-Miranda; Juan Pablo Peñaloza; Ingrid Araya-Durán; Rodrigo Reyes; Soledad Vidaurre; Valentina Romero; Juan Fuentes; Francisco Céric; Luis Velásquez; Fernando D González-Nilo; Carolina Otero
Journal:  Nanoscale Res Lett       Date:  2016-02-04       Impact factor: 4.703

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.